Understanding Levitra: Key Information and Uses

Overdose/Missed Dose
Drug Profile: Levitra
What are the differences between vardenafil and tadalafil?
Common side effects of Levitra vs. Cialis
Warnings of Levitra and Viagra

Quizartinib: (Major) Concomitant use of quizartinib and vardenafil increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Ranolazine: (Major) Concomitant use of vardenafil and ranolazine increases the risk of QT/QTc prolongation and torsade de pointes (TdP).

Overdose/Missed Dose

Oxaliplatin: (Major) Concomitant use of vardenafil and oxaliplatin increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Ozanimod: (Major) In general, do not initiate ozanimod in patients taking vardenafil due to the risk of additive bradycardia, QT prolongation, and torsade de pointes (TdP). If treatment initiation is considered, seek advice from a cardiologist. Ozanimod initiation may result in a transient decrease in heart rate and atrioventricular conduction delays. Ozanimod has not been studied in patients taking concurrent QT prolonging drugs; however, QT prolonging drugs have been associated with TdP in patients with bradycardia.

Which erectile dysfunction drug is best?

Pacritinib: (Major) Concomitant use of pacritinib and vardenafil increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Paliperidone: (Major) Concomitant use of vardenafil and paliperodone increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Panobinostat: (Major) QT prolongation has been reported with panobinostat therapy in patients with multiple myeloma in a clinical trial; use of panobinostat with other agents that online drugstore levitra prolong the QT interval is not recommended. Obtain an electrocardiogram at baseline and periodically during treatment. Hold panobinostat if the QTcF increases to >= 480 milliseconds during therapy; permanently discontinue if QT prolongation does not resolve.

How to Use Viagra™

Drugs with a possible risk for QT prolongation and torsade de pointes that should be used cautiously and with close monitoring with panobinostat include vardenafil. Pasireotide: (Moderate) Concomitant use of vardenafil and pasireotide may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Pazopanib: (Major) Concomitant use of vardenafil and pazopanib increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Pentamidine: (Major) Concomitant use of vardenafil and pentamidine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Perphenazine: (Minor) Use vardenafil with caution in combination with perphenazine due to increased risk of QT prolongation. Relugolix: (Moderate) Concomitant use of vardenafil and androgen deprivation therapy (i.e., relugolix) may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.

Aspect	Levitra (Vardenafil)	Sildenafil (Viagra)	Tadalafil (Cialis)
Onset of action	25-30 minutes	30-60 minutes	30-60 minutes
Duration	Up to 4-5 hours	Up to 4 hours	Up to 36 hours
Food interactions	Less affected by food	Delayed if taken after heavy meals	Less affected by food
Side effect profile	Similar to others, with possible visual disturbances	Similar, with some headache	Longer-lasting effect

Relugolix; Estradiol; Norethindrone acetate: (Moderate) Concomitant use of vardenafil and androgen deprivation therapy (i.e., relugolix) may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	40mg	20 Pills	67.56€ 64.34€
Levitra Generic	40mg	30 + 2 Pills	93.58€ 89.12€
Levitra Generic	10mg	60 + 6 Pills	112.98€ 107.60€
Levitra Generic	40mg	180 + 10 Pills	405.06€ 385.77€
Levitra Generic	60mg	90 + 6 Pills	291.82€ 277.92€
Levitra Generic	60mg	270 + 10 Pills	714.53€ 680.50€
Levitra Original	20mg	120 + 8 Pills	528.19€ 503.04€
Levitra Original	20mg	64 + 4 Pills	298.45€ 284.24€
Levitra Generic	60mg	30 + 2 Pills	109.43€ 104.22€
Levitra Professional	20mg	270 + 6 Pills	738.98€ 703.79€
Levitra Generic	40mg	10 Pills	41.37€ 39.40€
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€
Levitra Professional	20mg	30 Pills	119.12€ 113.45€
Levitra Soft Tabs	20mg	20 Pills	74.68€ 71.12€
Levitra Generic	10mg	20 Pills	46.54€ 44.32€
Levitra Soft Tabs	20mg	10 Pills	52.27€ 49.78€
Levitra Professional	20mg	360 + 6 Pills	914.63€ 871.08€

Ribociclib: (Major) Concurrent use of vardenafil orally disintegrating tablets with ribociclib should be avoided due to increased vardenafil exposure.

Levitra is approved for the treatment of erectile dysfunction in men over 18.
It is not recommended for use in women or children.
The medication is usually taken orally, in tablet form.
Levitra's effectiveness relies on sexual stimulation to initiate an erection.
Adverse effects are typically mild but can include dizziness and upset stomach.
Consult your healthcare provider if you experience prolonged or painful erections.
Levitra should be used cautiously in men with liver or kidney disease.
Always disclose your complete medical history to ensure safe use.

If use of vardenafil oral tablets and ribociclib is required, do not exceed a single dose of 2.5 mg per 24-hour period of vardenafil oral tablets. Also, coadministration of ribociclib with vardenafil should be avoided if possible due to an increased risk for QT prolongation.

Levitra is not suitable for men with severe liver or kidney impairment.
Do not take Levitra with other medications containing nitrates for chest pain.
Older adults should use Levitra with caution due to potential side effects.
Levitra is sometimes used in clinical trials for other conditions.
Keep Levitra out of reach of children due to potential toxicity.
Store Levitra in a cool, dry place and away from direct sunlight.
Patients should inform their healthcare provider about all current medications.
Levitra can cause priapism, a prolonged erection requiring medical attention.

Ribociclib has been shown to prolong the QT interval in a concentration-dependent manner.

Region/Country	Approval Status	Prescription Required	OTC Availability
USA	Approved by FDA	Yes	No
European Union	Approved by EMA	Yes	No
Australia	Approved by TGA	Yes	No
Canada	Approved by Health Canada	Yes	No

Vardenafil can produce QT prolongation at both therapeutic and supratherapeutic doses. Ribociclib; Letrozole: (Major) Concurrent use of vardenafil orally disintegrating tablets with ribociclib should be avoided due to increased vardenafil exposure.

Drug Profile: Levitra

Primaquine: (Moderate) Concomitant use of vardenafil and primaquine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Procainamide: (Major) Vardenafil should be avoided in patients taking Class IA antiarrhythmics (disopyramide, procainamide, and quinidine). Prochlorperazine: (Minor) Use vardenafil with caution in combination with prochlorperazine due to increased risk of QT prolongation. Prochlorperazine is also associated with a possible risk for QT prolongation. Promethazine: (Moderate) Concomitant use of promethazine and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Rilpivirine: (Moderate) Concomitant use of vardenafil and rilpivirine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.

Levitra is marketed by Bayer Pharmaceuticals in many countries worldwide.
It may be prescribed for off-label uses, such as pulmonary hypertension.
Levitra's effects can last up to 4-5 hours, providing a window for sexual activity.
Patients should avoid heavy meals before taking Levitra, as they can delay absorption.
Precautions include avoiding abrupt alcohol or drug use before taking the medication.
Levitra is sometimes used as an alternative to Viagra and Cialis.
Side effects are usually mild but should be reported to a doctor if persistent.
Levitra can interact with other medications, so full medical history is important.

Riociguat: (Contraindicated) Use of riociguat and vardenafil is contraindicated due to the risk of hypotension. Discontinue riociguat at least 24 hours prior to vardenafil administration. Monitor for signs and symptoms of hypotension during transition of therapy.

What are the differences between vardenafil and tadalafil?

Promethazine; Dextromethorphan: (Moderate) Concomitant use of promethazine and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Promethazine; Phenylephrine: (Moderate) Concomitant use of promethazine and vardenafil may increase liquid levitra the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Quetiapine: (Major) Concomitant use of vardenafil and quetiapine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Quinidine: (Major) Vardenafil should be avoided in patients taking Class IA antiarrhythmics (disopyramide, procainamide, and quinidine). Quinine: (Major) Concomitant use of vardenafil and quinine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). PDE5 inhibitors, including vardenafil, may potentiate the hypotensive effects of riociguat.

Common side effects of Levitra vs. Cialis

Perphenazine is associated with a possible risk for QT prolongation. Perphenazine; Amitriptyline: (Minor) Use vardenafil with caution in combination with perphenazine due to increased risk of QT prolongation. Phenoxybenzamine: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil. Phentolamine: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil. Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors.

Highlights of Cialis:

Pimavanserin: (Major) Concomitant use of vardenafil and pimavanserin increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Pimozide: (Contraindicated) Avoid concomitant use of vardenafil and pimozide due to an increased risk for torsade de pointes (TdP) and QT/QTc prolongation. Pitolisant: (Major) Concomitant use of vardenafil and pitolisant increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Ponesimod: (Major) In general, do not initiate ponesimod in patients taking vardenafil due to the risk of additive bradycardia, QT prolongation, and torsade de pointes (TdP). Ponesimod initiation may result in a transient decrease in heart rate and atrioventricular conduction delays.

Join the online physician networking revolution now

Ponesimod has not been studied in patients taking concurrent QT prolonging drugs; however, QT prolonging drugs have been associated with TdP in patients with bradycardia. Posaconazole: (Contraindicated) The concurrent use of posaconazole with drugs that are associated with QT prolongation and are also CYP3A4 substrates, such as vardenafil, is contraindicated. Posaconazole is associated with QT prolongation, and vardenafil may cause QT prolongation at both therapeutic and supratherapeutic doses. Elevated plasma concentrations of vardenafil may also increase the risk for other vardenafil-related adverse events, such as prolonged erection or potential for syncope. Prazosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil. Risperidone: (Moderate) Concomitant use of vardenafil and risperidone may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.

Warnings of Levitra and Viagra

Nirmatrelvir; Ritonavir: (Major) Consider withholding vardenafil during receipt of ritonavir-boosted nirmatrelvir. Coadministration may increase vardenafil exposure resulting in increased toxicity. Nitrates: (Contraindicated) Coadministration of phosphodiesterase inhibitors with organic nitrates or nitrites in any dosage formulation is contraindicated. Nitroglycerin: (Contraindicated) Coadministration of phosphodiesterase inhibitors with organic nitrates or nitrites in any dosage formulation is contraindicated. Nitroprusside: (Contraindicated) Concomitant use of nitroprusside and vardenafil is contraindicated due to the risk of additive hypotension.

Is 20 mg Levitra equal to 100 mg Viagra?

A suitable time interval after vardenafil dosing for the safe administration of nitrates has not been determined. In addition, vardenafil may potentiate the nitric oxide-mediated platelet anti-aggregatory effect of nitroprusside. Ofloxacin: (Moderate) Concomitant use of ofloxacin and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Olanzapine: (Moderate) Concomitant use of vardenafil and olanzapine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Olanzapine; Fluoxetine: (Moderate) Concomitant use of vardenafil and fluoxetine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.

Professional resources

(Moderate) Concomitant use of vardenafil and olanzapine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Olanzapine; Samidorphan: (Moderate) Concomitant use of vardenafil and olanzapine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Ondansetron: (Major) Concomitant use of ondansetron and vardenafil increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Osilodrostat: (Moderate) Concomitant use of vardenafil and osilodrostat may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Osimertinib: (Major) Concomitant use of vardenafil and osimertinib increases the risk of QT/QTc prolongation and torsade de pointes (TdP).